Geron GERN
NASDAQ GERN
$1.38 -0.02 (-1.78%)
As of: Sep 10, 2026 · 3:59 PM EDT

Geron (GERN) Common Equity (2010 - 2026)

Geron's (GERN) quarterly Common Equity came in at $218.6 million in Q2 2026, down 15.77% year-over-year from $259.5 million in Q2 2025, and down 4.58% quarter-over-quarter from $229.1 million in Q1 2026.

Analysis

Geron (GERN) Common Equity (2010 - 2026) Analysis & Trends

Geron has disclosed Common Equity across 17 years of filings, most recently posting $218.6 million for Q2 2026.

  • In Q2 2026, Common Equity fell 15.77% year-over-year to $218.6 million; the TTM figure through Jun 2026 stood at $218.6 million (down 15.77% YoY), while the FY2025 annual figure was $225.9 million, down 19.42% from the prior year.
  • Common Equity came in at $218.6 million for Q2 2026 at Geron, down from $229.1 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $344.9 million in Q1 2024 to a low of $80.0 million in Q4 2022.
  • Average Common Equity over 5 years is $236.9 million, with a median of $254.1 million recorded in 2025.
  • Year-over-year, Common Equity tumbled 51.54% in 2022 and surged 234.46% in 2023.
  • Over 5 years, Common Equity stood at $80.0 million in 2022, then jumped by 209.94% to $247.9 million in 2023, then grew by 13.06% to $280.3 million in 2024, then dropped by 19.42% to $225.9 million in 2025, then slipped by 3.21% to $218.6 million in 2026.
  • Per Business Quant data, the three most recent Common Equity figures were $218.6 million in Q2 2026, $229.1 million in Q1 2026, and $225.9 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 11.69 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 11.83 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 20.25 Bn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 31.71 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn 8.42 Bn
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 6.76 Bn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 1.35 Bn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 18.85 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn 4.92 Bn
10 Geron 914.60 Mn 613.75 Mn - 218.61 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 218.61 Mn
Mar 31, 2026 229.11 Mn
Dec 31, 2025 225.87 Mn
Sep 30, 2025 248.71 Mn
Jun 30, 2025 259.53 Mn
Mar 31, 2025 268.24 Mn
Dec 31, 2024 280.32 Mn
Sep 30, 2024 292.28 Mn
Jun 30, 2024 306.70 Mn
Mar 31, 2024 344.87 Mn
Dec 31, 2023 247.95 Mn
Sep 30, 2023 290.61 Mn
Jun 30, 2023 298.43 Mn
Mar 31, 2023 326.06 Mn
Dec 31, 2022 80.00 Mn
Sep 30, 2022 108.17 Mn
Jun 30, 2022 142.05 Mn
Mar 31, 2022 97.49 Mn
Dec 31, 2021 126.42 Mn
Sep 30, 2021 151.55 Mn